NO20060607L - Ny fremgangsmate - Google Patents
Ny fremgangsmateInfo
- Publication number
- NO20060607L NO20060607L NO20060607A NO20060607A NO20060607L NO 20060607 L NO20060607 L NO 20060607L NO 20060607 A NO20060607 A NO 20060607A NO 20060607 A NO20060607 A NO 20060607A NO 20060607 L NO20060607 L NO 20060607L
- Authority
- NO
- Norway
- Prior art keywords
- new procedure
- producing
- high yield
- new process
- small crystal
- Prior art date
Links
- 239000013078 crystal Substances 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D9/00—Crystallisation
- B01D9/005—Selection of auxiliary, e.g. for control of crystallisation nuclei, of crystal growth, of adherence to walls; Arrangements for introduction thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D9/00—Crystallisation
- B01D9/005—Selection of auxiliary, e.g. for control of crystallisation nuclei, of crystal growth, of adherence to walls; Arrangements for introduction thereof
- B01D9/0054—Use of anti-solvent
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D9/00—Crystallisation
- B01D9/0063—Control or regulation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D9/00—Crystallisation
- B01D9/0081—Use of vibrations, e.g. ultrasound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
- Silicon Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0302029A SE0302029D0 (sv) | 2003-07-07 | 2003-07-07 | Novel process |
| PCT/GB2004/002882 WO2005004847A1 (en) | 2003-07-07 | 2004-07-05 | Novel process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20060607L true NO20060607L (no) | 2006-04-07 |
Family
ID=27764955
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20060607A NO20060607L (no) | 2003-07-07 | 2006-02-07 | Ny fremgangsmate |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20060188579A1 (pt) |
| EP (1) | EP1648414A1 (pt) |
| JP (1) | JP2007527381A (pt) |
| KR (1) | KR20060052779A (pt) |
| CN (1) | CN1819818A (pt) |
| AU (1) | AU2004255517A1 (pt) |
| BR (1) | BRPI0412445A (pt) |
| CA (1) | CA2531025A1 (pt) |
| IL (1) | IL172771A0 (pt) |
| MX (1) | MXPA05014075A (pt) |
| NO (1) | NO20060607L (pt) |
| SE (1) | SE0302029D0 (pt) |
| WO (1) | WO2005004847A1 (pt) |
| ZA (1) | ZA200600110B (pt) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20032054A1 (it) | 2003-10-22 | 2005-04-23 | Monteres S R L | Processo per la preparazione di sospensioni farmaceutiche da inalare. |
| ATE552032T1 (de) | 2005-07-14 | 2012-04-15 | Lithera Inc | Verbesserte lipolytikum-formulierung mit hinhaltender wirkstofffreigabe für die arealbehandlung von fettgewebe |
| ES2398480T3 (es) * | 2006-10-17 | 2013-03-19 | Lithera, Inc. | Procedimientos, composiciones, y formulaciones para el tratamiento de la enfermedad ocular tiroidea |
| GB0806873D0 (en) * | 2008-04-16 | 2008-05-21 | Breath Ltd | Steroid nebuliser formulation |
| EP2321022B1 (en) * | 2008-07-18 | 2016-11-02 | Prosonix Limited | Process for improving crystallinity |
| US9132084B2 (en) | 2009-05-27 | 2015-09-15 | Neothetics, Inc. | Methods for administration and formulations for the treatment of regional adipose tissue |
| KR20120113267A (ko) * | 2010-01-15 | 2012-10-12 | 리쎄라 인코오포레이티드 | 동결건조 케이크 제제 |
| AU2011305567A1 (en) | 2010-09-22 | 2013-05-02 | Map Pharmaceuticals, Inc. | Corticosteroid particles and method of production |
| CN103269693A (zh) | 2010-11-24 | 2013-08-28 | 利赛拉公司 | 选择性、亲脂性及长效型β激动剂单一治疗调配物和用于肥胖及外形凸起的美容治疗的方法 |
| CN103429267B (zh) * | 2011-01-09 | 2016-05-04 | Anp科技公司 | 疏水分子诱导的支化聚合物集合体及其用途 |
| CN102807585B (zh) * | 2012-08-06 | 2015-08-12 | 广西田园生化股份有限公司 | 一种采用超声波辅助技术结晶毒氟磷的方法 |
| CN103588846B (zh) * | 2012-08-15 | 2016-08-03 | 重庆华邦制药有限公司 | 一种丙酸氟替卡松微粒的制备方法及其用途 |
| US9855538B2 (en) | 2013-03-08 | 2018-01-02 | The Board Of Trustees Of The University Of Illinois | Ultrasonic method and apparatus for producing particles having a controlled size distribution |
| CN109988074A (zh) * | 2018-06-01 | 2019-07-09 | 药璞(上海)医药科技有限公司 | 一种适合药用的硫酸特布他林晶型b的制备方法 |
| WO2022134000A1 (zh) * | 2020-12-25 | 2022-06-30 | 深圳晶泰科技有限公司 | 连续激发结晶的方法及系统 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9501384D0 (sv) * | 1995-04-13 | 1995-04-13 | Astra Ab | Process for the preparation of respirable particles |
| GB9828721D0 (en) * | 1998-12-24 | 1999-02-17 | Glaxo Group Ltd | Novel apparatus and process |
| GB0016040D0 (en) * | 2000-06-29 | 2000-08-23 | Glaxo Group Ltd | Novel process for preparing crystalline particles |
| EP1409101B1 (en) * | 2001-05-05 | 2006-04-12 | Accentus plc | Formation of small crystals |
| GB0125604D0 (en) * | 2001-10-25 | 2001-12-19 | Glaxo Group Ltd | Novel process |
| ATE551993T1 (de) * | 2002-10-17 | 2012-04-15 | Boehringer Ingelheim Pharma | Verfahren und reaktor zur herstellung von pulvern für inhalative medikamente |
-
2003
- 2003-07-07 SE SE0302029A patent/SE0302029D0/xx unknown
-
2004
- 2004-07-05 WO PCT/GB2004/002882 patent/WO2005004847A1/en not_active Ceased
- 2004-07-05 JP JP2006518339A patent/JP2007527381A/ja active Pending
- 2004-07-05 CA CA002531025A patent/CA2531025A1/en not_active Abandoned
- 2004-07-05 KR KR1020067000285A patent/KR20060052779A/ko not_active Withdrawn
- 2004-07-05 BR BRPI0412445-6A patent/BRPI0412445A/pt not_active Application Discontinuation
- 2004-07-05 AU AU2004255517A patent/AU2004255517A1/en not_active Abandoned
- 2004-07-05 US US10/563,685 patent/US20060188579A1/en not_active Abandoned
- 2004-07-05 MX MXPA05014075A patent/MXPA05014075A/es not_active Application Discontinuation
- 2004-07-05 CN CNA2004800196007A patent/CN1819818A/zh active Pending
- 2004-07-05 EP EP04743228A patent/EP1648414A1/en not_active Withdrawn
-
2005
- 2005-12-22 IL IL172771A patent/IL172771A0/en unknown
-
2006
- 2006-01-05 ZA ZA200600110A patent/ZA200600110B/en unknown
- 2006-02-07 NO NO20060607A patent/NO20060607L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| SE0302029D0 (sv) | 2003-07-07 |
| IL172771A0 (en) | 2006-04-10 |
| CN1819818A (zh) | 2006-08-16 |
| EP1648414A1 (en) | 2006-04-26 |
| ZA200600110B (en) | 2007-01-31 |
| CA2531025A1 (en) | 2005-01-20 |
| US20060188579A1 (en) | 2006-08-24 |
| WO2005004847A1 (en) | 2005-01-20 |
| BRPI0412445A (pt) | 2006-09-19 |
| KR20060052779A (ko) | 2006-05-19 |
| AU2004255517A1 (en) | 2005-01-20 |
| JP2007527381A (ja) | 2007-09-27 |
| MXPA05014075A (es) | 2006-03-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20060607L (no) | Ny fremgangsmate | |
| NO20052244D0 (no) | Enantioselektiv fremgangsmate for fremstilling av begge enantiomerene av 10,11- dihydro-10-hydroksy-5H-dibenzo[b,f]- azepin-5-karboksamid og nye krystallformer derav | |
| NO20051118L (no) | Fremgangsmate til fremstilling av amorfe og keramiske materialer via smeltespinning | |
| NO20034366L (no) | Apparatur og produksjonsmetode for produksjon av hydrogen med höyt trykk | |
| AU2003268522A8 (en) | Apparatus and process for production of high purity hydrogen | |
| TW200512191A (en) | Methods and compounds producing dipeptidyl peptidase iv inhibitors and intermediates thereof | |
| NO20024319L (no) | Fremgangsmåte og anordning for syretilsetning av hydrokarbonkilder | |
| NO20035669D0 (no) | Kvartsglassdigel og fremgangsmåte for fremstilling derav | |
| ATE454938T1 (de) | Düsen und komponenten davon sowie herstellungsverfahren dafür | |
| ATE415402T1 (de) | Modifizierte pictet-spengler-reaktion und damit hergestellte verbindungen | |
| ECSP095220A (es) | Derivados de n-fenil-2-pirimidin-amina | |
| NO20071937L (no) | Fremgangsmater og mellomprodukter for fremstilling av cysteinproteaseinhibitorer | |
| AU2003270022A1 (en) | Method and apparatus for the manufacture of high temperature materials by combustion synthesis and semi-solid forming | |
| DE60329706D1 (de) | Festphase fluorierung von benzothiazole | |
| TW200508233A (en) | Chk-1 inhibitors | |
| EP1471578A4 (en) | METHOD OF MANUFACTURING SOI WAFERS AND SOI WAFERS | |
| NO20051393L (no) | Prosess og intermediater for fremstilling av tienopyrrol-derivater | |
| NO20083269L (no) | Prosess for a anvende krystallinsk orlistatmetoder | |
| MY138550A (en) | Method for synthesis of perindopril and its pharmaceutically acceptable salts | |
| NO20064012L (no) | Kjemisk prosess | |
| MY135359A (en) | New process for the synthesis of perindopril and pharmaceutically acceptable salts thereof | |
| MXPA05005574A (es) | Compuestos calciliticos. | |
| NO20072431L (no) | Fremgangsmate og intermediater for fremstilling av N-(1-benzohydryl-azetidin-3-yl-)-N-fenyl-metylsulfonamid-derivater | |
| AU2003220910A1 (en) | Process for production of fullerenes and method for separation thereof | |
| MY136288A (en) | New process for the synthesis of perindopril and its pharmaceutically acceptable salts |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |